PFM Health Sciences’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-126,989
| Closed | -$61.6M | – | 76 |
|
|
2025
Q1 | $61.6M | Hold |
126,989
| – | – | 4.47% | 6 |
|
|
2024
Q4 | $51.1M | Sell |
126,989
-21,863
| -15% | -$8.8M | 3.17% | 5 |
|
|
2024
Q3 | $69.2M | Hold |
148,852
| – | – | 3.92% | 5 |
|
|
2024
Q2 | $69.8M | Hold |
148,852
| – | – | 3.45% | 5 |
|
|
2024
Q1 | $62.2M | Hold |
148,852
| – | – | 2.93% | 6 |
|
|
2023
Q4 | $60.6M | Buy |
+148,852
| New | +$60.6M | 3.63% | 5 |
|
|
2021
Q2 | – | Sell |
-46,889
| Closed | -$10.1M | – | 88 |
|
|
2021
Q1 | $10.1M | Buy |
+46,889
| New | +$10.1M | 0.31% | 56 |
|
|
2020
Q3 | – | Sell |
-59,035
| Closed | -$17.1M | – | 85 |
|
|
2020
Q2 | $17.1M | Sell |
59,035
-36,447
| -38% | -$10.6M | 0.89% | 35 |
|
|
2020
Q1 | $22.7M | Buy |
95,482
+38,560
| +68% | +$9.18M | 1.87% | 22 |
|
|
2019
Q4 | $12.5M | Buy |
+56,922
| New | +$12.5M | 0.59% | 39 |
|
|
2016
Q3 | – | Sell |
-135,487
| Closed | -$11.7M | – | 98 |
|
|
2016
Q2 | $11.7M | Buy |
+135,487
| New | +$11.7M | 0.35% | 57 |
|